Bullous SLE: response to methotrexate and relationship with disease activity
暂无分享,去创建一个
[1] E. Sato. Methotrexate therapy in systemic lupus erythematosus , 2001, Lupus.
[2] T. Chen,et al. Concomitant lupus nephritis and bullous eruption in systemic lupus erythematosus. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[3] E. Sato,et al. Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus. , 1999, The Journal of rheumatology.
[4] R. Bauer,et al. Management of cutaneous lupus erythematosus with low-dose methotrexate: indication for modulation of inflammatory mechanisms , 1998, Rheumatology International.
[5] S. Gansauge,et al. Methotrexate in patients with moderate systemic lupus erythematosus (exclusion of renal and central nervous system disease) , 1997, Annals of the rheumatic diseases.
[6] J. Callen. Bullous systemic lupus erythematosus: revised criteria for diagnosis , 1995 .
[7] R. Briggaman,et al. Bullous SLE: a phenotypically distinctive but immunologically heterogeneous bullous disorder. , 1993, The Journal of investigative dermatology.
[8] C. Camisa. Vesiculobullous systemic lupus erythematosus. A report of four cases. , 1988, Journal of the American Academy of Dermatology.
[9] J. Fine,et al. Bullous systemic lupus erythematosus: an unusual clinical course and detectable circulating autoantibodies to the epidermolysis bullosa acquisita antigen. , 1986, Journal of the American Academy of Dermatology.
[10] R. Hall,et al. Bullous eruption of systemic lupus erythematosus. Dramatic response to dapsone therapy. , 1982, Annals of internal medicine.